Peter Shaw

Title: Peter Shaw: Innovator in Cardiovascular Genetics

Introduction

Peter Shaw is a notable inventor based in Yardley, PA (US). He has made significant contributions to the field of genetics, particularly in understanding cardiovascular disorders. With a total of 6 patents to his name, Shaw's work has the potential to impact medical treatments and patient outcomes.

Latest Patents

One of Shaw's latest patents focuses on genetic polymorphisms associated with cardiovascular disorders and drug response. This invention is based on the discovery of genetic variations linked to acute coronary events, such as myocardial infarction and stroke. It also addresses how individuals respond to treatment for cardiovascular disorders with statins. The patent details nucleic acid molecules containing these polymorphisms, variant proteins encoded by them, and reagents for detecting both the nucleic acids and proteins. Furthermore, it outlines methods for utilizing these nucleic acids and proteins, as well as the reagents for their detection.

Career Highlights

Throughout his career, Peter Shaw has worked with prominent companies in the pharmaceutical and biotechnology sectors. Notably, he has been associated with Bristol-Myers Squibb Company and Celera Corporation. His experience in these organizations has contributed to his expertise in genetic research and innovation.

Collaborations

Shaw has collaborated with several professionals in his field, including Olga Iakoubova and James J. Devlin. These collaborations have likely enriched his research and contributed to the development of his patents.

Conclusion

Peter Shaw's innovative work in the realm of cardiovascular genetics showcases his dedication to advancing medical science. His patents not only highlight his expertise but also hold promise for improving treatment strategies for cardiovascular disorders.